- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07761208
Turkish Version of the Pictorial Pain Interference Questionnaire
August 8, 2026 updated by: Yunus Emre Tutuneken, Istinye University
Assessment of the Functional Impact of Chronic Pain: Psychometric Properties of the Turkish Version of the Pictorial Pain Interference Questionnaire
This study aims to culturally adapt the Pictorial Pain Interference Questionnaire into Turkish and evaluate its psychometric properties in individuals with chronic pain.
The study will assess the validity and reliability of the Turkish version for evaluating the functional impact of chronic pain on daily life activities.
Reliability will be examined through internal consistency and test-retest reliability, while validity will be assessed by examining the relationships between the questionnaire and established pain-related assessment tools.
The study will determine whether the Turkish version provides a valid, reliable, and practical instrument for assessing functional interference associated with chronic pain in Turkish-speaking individuals.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adults aged 18 years and older with chronic pain lasting for at least 3 months
Description
Inclusion Criteria:
- Having chronic pain lasting for at least 3 months.
- Willing to participate in the study and providing informed consent.
- Having sufficient cognitive ability to understand the questions.
Exclusion Criteria:
- Severe cognitive impairment (e.g., dementia) or conditions that interfere with communication.
- Inability to cooperate due to a psychiatric disorder.
- Neurological or serious systemic diseases that may affect the assessment.
- Incomplete or incorrectly completed questionnaires.
- Refusal to participate or withdrawal from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internal Consistency of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: At the first assessment (Baseline)
|
Internal consistency will be assessed using Cronbach's alpha coefficient.
|
At the first assessment (Baseline)
|
|
Test-Retest Reliability of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: Baseline and 7 days
|
Test-retest reliability will be assessed using the Intraclass Correlation Coefficient (ICC) based on assessments performed 7 days apart.
|
Baseline and 7 days
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Brief Pain Inventory.
|
Baseline
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Pain Disability Index.
|
Baseline
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Oswestry Disability Index.
|
Baseline
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Short-Form McGill Pain Questionnaire.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Discriminant Validity of the Turkish Pictorial Pain Interference Questionnaire
Time Frame: Baseline
|
Discriminant validity will be assessed by examining correlations with concepts expected to have weak associations with pain, including positive affect.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 20, 2026
Primary Completion (Estimated)
February 15, 2027
Study Completion (Estimated)
February 22, 2027
Study Registration Dates
First Submitted
August 8, 2026
First Submitted That Met QC Criteria
August 8, 2026
First Posted (Actual)
August 12, 2026
Study Record Updates
Last Update Posted (Actual)
August 12, 2026
Last Update Submitted That Met QC Criteria
August 8, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 101 (Hamilton Integrated Research Ethics Board)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.